Suppression of major histocompatibility complex (MHC) class II antigen presentation is believed to be among the major mechanisms used by Mycobacterium tuberculosis to escape protective host immune responses. Through a genome-wide screen for the genetic loci of M. tuberculosis that inhibit MHC class II-restricted antigen presentation by mycobacteriainfected dendritic cells, we identified the PE_PGRS47 protein as one of the responsible factors. Targeted disruption of the PE_PGRS47 (Rv2741) gene led to attenuated growth of M. tuberculosis in vitro and in vivo, and a PE_PGRS47 mutant showed enhanced MHC class II-restricted antigen presentation during in vivo infection of mice. Analysis of the effects of deletion or over-expression of PE_PGRS47 implicated this protein in the inhibition of autophagy in infected host phagocytes. Our findings identify PE_PGRS47 as a functionally relevant, non-redundant bacterial factor in the modulation of innate and adaptive immunity by M. tuberculosis, suggesting strategies for improving antigen presentation and the generation of protective immunity during vaccination or infection. T-cell responses, are critical for host resistance to Mtb, and the bacilli have evolved the ability to modulate the expression and function of these molecules 2-8 . Autophagy is a ubiquitous cellular process that participates in the processing of antigens for MHC class II antigen presentation [9] [10] [11] [12] , and in cells infected by vacuolar pathogens like Mtb it provides a potential mechanism to initiate phagosome maturation and enhance the processing and presentation of their antigens to T cells [12] [13] [14] . Recent evidence suggests that Mtb has developed immune evasion strategies that interfere with autophagy, thus improving its intracellular survival and limiting the presentation of its antigens by MHC class II. Although several mycobacterial factors have been implicated in this aspect of immune evasion [15] [16] [17] , the mechanisms and specific mediators involved remain mostly unknown.
M ycobacterium tuberculosis (Mtb) persists within mammalian hosts through a variety of immune evasion strategies, including the inhibition of multiple antigen presentation pathways that are central to adaptive immunity 1 . Major histocompatibility complex (MHC) class II molecules, which control CD4 + T-cell responses, are critical for host resistance to Mtb, and the bacilli have evolved the ability to modulate the expression and function of these molecules [2] [3] [4] [5] [6] [7] [8] . Autophagy is a ubiquitous cellular process that participates in the processing of antigens for MHC class II antigen presentation [9] [10] [11] [12] , and in cells infected by vacuolar pathogens like Mtb it provides a potential mechanism to initiate phagosome maturation and enhance the processing and presentation of their antigens to T cells [12] [13] [14] . Recent evidence suggests that Mtb has developed immune evasion strategies that interfere with autophagy, thus improving its intracellular survival and limiting the presentation of its antigens by MHC class II. Although several mycobacterial factors have been implicated in this aspect of immune evasion [15] [16] [17] , the mechanisms and specific mediators involved remain mostly unknown.
In the current study, we undertook a genome-wide gain of function screen to identify genes of Mtb involved in the inhibition of MHC class II presentation in Mtb-infected cells. This identified at least five genomic loci of Mtb that independently contribute to the inhibition of MHC class II-restricted antigen presentation, several of which also blocked autophagy. Detailed analysis of one of these loci implicated PE_PGRS47, a member of a large family of virulence-related genes in Mtb, as an inhibitor of autophagy and a factor contributing to evasion of both innate and adaptive immunity by Mtb. These findings identify a specific mycobacterial factor involved in the evasion of innate and adaptive immunity against Mtb and provide new insight into the role of PE_PGRS proteins in tuberculosis.
Results

Isolation of Mtb genes that inhibit MHC class II presentation.
A cosmid library of random Mtb genomic DNA fragments (∼20-35 kilobases) was used to transform the nonpathogenic mycobacterium M. smegmatis (Msmeg), and several hundred individual clones were screened for their ability to impair MHC class II presentation of bacterial antigens by bone marrow-derived dendritic cells (BMDCs). We used Msmeg expressing an Mtb ESAT-6 protein extended at its C terminus to include a well-characterized MHC class II presented epitope (I-Eα 52-68 ) for this screening, which allowed direct measurement of antigen presentation using monoclonal antibody Y-Ae, specific for complexes of I-Eα 52-68 bound to MHC class II (I-A b ) molecules 18 ( Supplementary Fig. 1 ). From a total of 365 Msmeg transformants harbouring random Mtb genomic cosmids, five were identified that gave a significant and reproducible reduction of cell surface Y-Ae staining while maintaining the expression of the ESAT6-IEα fusion protein ( Fig. 1a and Supplementary Fig. 2 ). Restriction mapping of re-extracted cosmid DNA revealed that each cosmid contained distinct and nonoverlapping inserts of Mtb genomic DNA ( Supplementary Fig. 2 ). None of these Msmeg clones affected the level of total cell surface MHC class II expression on infected BMDCs (Fig. 1b) . This indicated that the reduced antigen presentation was not due to global down-regulation of MHC class II expression, which has been previously attributed to Mtb (ref. 5) . The reduction in cell surface expression of MHC class II/peptide complexes was also confirmed in assays of T-cell responses using CD4 + T cells specific for I-A b /Eα 52-68 peptide complexes (Fig. 1c) . Taken together, our results indicate at least five genomic loci in Mtb encoding the potential to inhibit the processing or presentation of bacteria-derived MHC class II presented antigens.
Effects of Mtb genes on autophagy. The inhibition of antigen presentation by Mtb genes without reduction in total surface MHC class II suggested effects on the digestion of intraphagosomal bacteria and reduced delivery of their antigens to endocytic compartments containing MHC class II molecules.
Consistent with this, we observed that three of the five Msmeg transformants inhibiting antigen presentation showed a significant increase in persistence of viable bacteria at 24 h following in vitro infection of BMDCs (Fig. 1d) . These findings suggested an effect on autophagy, a basic cellular process that restricts the survival of intracellular mycobacteria 13, 14, 19 and also promotes intracellular antigen processing for MHC class II presentation 20 . To examine this, we assessed the distribution of microtubule-associated light chain 3 (LC3), a central component of autophagosome formation that undergoes cleavage, lipid modification and cellular redistribution during autophagosome formation 21 . Initial experiments showed that infection of a macrophage cell line with wild-type Msmeg triggered the formation of LC3 punctate structures in the cytoplasm, which were visualized by staining All ΔMFI values are plotted as a percentage of the value for the pYUB412 control, which was normalized to 100. b, BMDCs were infected as in a, but stained with mAb specific for total MHC class II. Values are plotted as MFI of surface staining as a percentage of the pYUB412 control (hatched bar), which was normalized to 100. c, Cells from a Th1-polarized CD4 + T-cell line derived from TEα TCR transgenic mice were cultured with BMDCs infected as outlined in a. Supernatants were collected after 72 h and the levels of IFNγ were measured by capture ELISA. d, BMDCs were infected as in a. Cells were collected after 24 h of incubation and lysates were plated to determine the number of intracellular viable bacteria. e, Fluorescence images of AMJ2-C8 infected as in a and immunostained with anti-LC3 and with DAPI after a total of 24 h. Representative images of cells uninfected or infected with Msmeg transformed with empty cosmid (pYUB412), or with cosmids M2H3 or M2D10 (green, LC3; blue, DAPI). Scale bars, 20 µm. f, Quantitative analysis of the percentages of LC3 + punctate foci per cell for all five cosmids. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 compared to control (pYUB412) values (one-way analysis of variance (ANOVA) with Dunnett's multiple comparisons post-test). All values are plotted as means ± 1 s.e. of triplicate measurements and the results are representative of a minimum of three independent experiments (a-d) and two independent experiments (e,f). Means and s.e. are indicated in red. with an anti-LC3 mAb. In contrast, infections with Msmeg transformed with cosmid M2D10, M2H6 or S1G7 were associated with a significant reduction of the LC3 puncta formation as compared with cells infected with control Msmeg harbouring empty cosmid (pYUB412; Fig. 1e,f ) . Similar results were obtained using an LC3-GFP reporter fusion protein ( Supplementary  Fig. 3a,b) . Biochemical analysis of LC3 protein also confirmed an effect on autophagy, showing that the increase in the LC3-II/LC3-I ratio was substantially reduced (25-85%) in cells infected with bacteria harbouring the same cosmids that reduced LC3 puncta formation ( Supplementary Fig. 3c ).
Identification of PE_PGRS47 as an autophagy-inhibiting Mtb gene. As a first step towards the identification of specific Mtb genes responsible for the inhibition of autophagy and antigen presentation, we focused on cosmid M2D10 and generated a complete map of open reading frames (ORFs) from the sequence of its ∼35 kb insert ( Supplementary Fig. 4 ). Based on annotation of the Mtb genome and published literature, one gene among the 33 intact ORFs stood out as a candidate for direct involvement in host-pathogen interactions. This was PE_PGRS47 (Rv2741), a member of the large family of PE_PGRS genes implicated in pathogenesis and intracellular survival of virulent mycobacteria ( Supplementary Fig. 5 ) 22, 23 . Initial experiments showed that expression of PE_PGRS47 in Msmeg phenocopied the inhibition of autophagy in infected macrophages observed with Msmeg transformed with cosmid M2D10, and also demonstrated that PE_PGRS47 was secreted by the bacteria and could gain access to the cytosol of infected phagocytic cells (Supplementary Fig. 6 ). We thus proceeded to directly explore the role of PE_PGRS47 in Mtb infection by constructing a precise deletion mutant in the virulent Mtb H37Rv strain using specialized phage transduction ( Supplementary Fig. 7a-d ) 24 . In addition, a complemented strain was generated by reintroducing PE_PGRS47 into the ΔPE_PGRS47 mutant. The ΔPE_PGRS47 and complemented strains showed identical growth in standard liquid medium as wild-type Mtb, and similar growth in vivo in the lungs during the first four weeks following low-dose aerosol infection of C57BL/6 mice ( Supplementary Fig. 7e,f ) .
To assess the role of PE_PGRS47 in blocking autophagy during Mtb infection, mouse macrophage cell line RAW264.7 was infected with wild-type, mutant or complemented strains and examined for LC3 punctate structures by fluorescence microscopy. This revealed an increase in LC3 puncta with infection by the mutant (Fig. 2a,b) . Following infection of RAW264.7 cells with the ΔPE_PGRS47 mutant we also observed an increase in conversion of LC3-I to 
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Δ P E _ P G R S 4 7 ) treatment for 1 h. Cultures were incubated for an additional 20 h and then collected, lysed and plated to determine c.f.u. of viable bacteria. Where indicated, 3-methyladenine (3MA, 5 mM) was added 1 h before infection. This experiment was performed twice and representative results are shown. *P < 0.05, **P < 0.01 for Mtb WT versus ΔPE_PGRS47 (one-way ANOVA with Dunnett's post-test). NS, not significant.
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-II compared to cells infected with wild-type or complemented strains (Fig. 2c) . We also examined effects on the levels of p62 (sequestosome 1), which is recruited to newly formed autophagosomes and subsequently degraded 25 . We observed a greater level of p62 in cells infected with wild-type Mtb than ΔPE_PGRS47 mutant infection, which was reversed by complementation ( Fig. 2d) . Furthermore, using wild-type, ΔPE_PGRS47 and complemented strains of Mtb expressing TdTomato, an increase in the colocalization of intracellular bacteria with LC3 punctate structures was shown for the ΔPE_PGRS47 mutant in infected RAW264.7 cells (Fig. 2e,f ) . Transmission electron microscopy of cells infected with the mutant showed bacilli within the characteristic double-membrane autophagosomes associated with the initial stages of engulfment by autophagy; such structures were not observed in cells infected with wild-type Mtb (Fig. 2g) . Altogether, these results indicate a significant role for PE_PGRS47 in preventing the formation or a detectable level of accumulation of autophagosomes containing intracellular Mtb.
Effects of PE_PGRS47 on maturation of mycobacterial phagosomes. The engulfment of mycobacteria within autophagosomes can lead to further maturation of these compartments, including acidification and fusion with lysosomes. We thus carried out studies to assess the role of PE_PGRS47 in blocking mycobacterial phagosome acidification and phagolysosomal fusion. RAW264.7 cells were labelled with LysoTracker dye, which labels acidic late endosomes and lysosomes, and then infected with wild-type, ΔPE_PGRS47 or complemented strains of Mtb. This revealed a significant increase ) treatment for 1 h and then incubation with TB9.8-specific (left) or Ag85B-specific (right) T-cell hybridomas for an additonal 20 h. Rapamycin (Rapa, 1 mM) or 3-methyladenine (3MA, 5 mM) was added to some cultures as indicated 1 h before infection. Concentrations of IL-2 were determined from triplicate wells by ELISA and values are plotted as means ± 1 s.e. Background levels of IL-2 in cultures with no mycobacterial infection were <0.1 ng ml -1 for both T-cell hybridomas. Asterisks indicate significant differences compared to WT Mtb (**P < 0.01 and ***P < 0.001); NS, not significant compared to Mtb WT (two-way ANOVA with Dunnett's post-test). b, Lack of effect of PE_PGRS47 expression on surface MHC class II levels of infected BMDCs. Cultures of BMDCs were infected with the indicated bacteria at an MOI of 10:1 for 3 h followed by gentamicin (100 µg ml in co-localization with the mutant compared to wild-type Mtb, which was reversed by complementation (Fig. 3a,b) . We also observed a significant increase in co-localization between the ΔPE_PGRS47 mutant and the lysosomal marker lysosome-associated membrane protein 1 (LAMP-1) (Fig. 3a,b) , indicating enhanced lysosomal fusion with infected phagosomes.
Role of PE_PGRS47 during chronic Mtb infection. Whereas initial findings showed that deletion of PE_PGRS47 had no effect on the growth of Mtb in mice early after infection ( Supplementary Fig. 7f ), subsequent analysis of colony-forming unit (c.f.u.) levels from tissues of wild-type mice at 15 or 25 weeks post-infection showed that the ΔPE_PGRS47 strain was significantly attenuated in chronic stages of disease (Fig. 4a) . Histological examination of the lungs at 15 weeks post-infection showed reductions in leukocyte accumulation and in the total area of histologically inflamed lung tissue in animals infected with the mutant compared to wild-type or complemented strains (Fig. 4b) . To examine this in the absence of adaptive immunity, severe combined immunodeficient (SCID) mice were infected intravenously with a high dose (10 6 c.f.u.) of Mtb mutant, wildtype and complemented strains, then followed for survival. This also showed that the ΔPE_PGRS47 strain was significantly attenuated in vivo (Fig. 4c) , indicating an increased susceptibility to innate immune mechanisms. Similarly, in vitro infection in RAW264.7, human THP-1 myelomonocytic cells and BMDCs showed that the mutant had very little capacity for intracellular growth, remaining at static levels based on sampling at various intervals during the five days of culture compared to the wild-type or complemented strains ( Supplementary Fig. 8a ). To confirm a role for autophagy in this reduced intracellular survival of ΔPE_PGRS47, we infected RAW264.7 cells or BMDCs with the ΔPE_PGRS47, wild-type Mtb and complemented strains in the presence or absence of 3-methyladenine (3MA), an inhibitor of autophagy. This showed that the reduced bacterial burden of the ΔPE_PGRS47 mutant could be fully restored to wild-type Mtb levels by the addition of 3MA (Fig. 4d) . In contrast, no significant changes in c.f.u. levels were observed with 3MA treatment of cells infected with wild-type Mtb or complemented strains ( Supplementary Fig. 8b ). These results are consistent with an important role for the PE_PGRS47 gene in the growth and survival of Mtb, particularly during intracellular growth and in the later chronic phase of infection.
Inhibition of MHC class II antigen presentation by PE_PGRS47.
To assess the ability of PE_PGRS47 to suppress MHC class II dependent antigen presentation during Mtb infection, we carried out studies both in vitro and in vivo. Presentation to MHC class II-restricted T-cell hybridomas was assessed in vitro for BMDCs infected with the ΔPE_PGRS47 mutant compared to wild-type or complemented strains. This showed enhanced responses for hybridomas specific for Mtb secreted antigens TB9.8 or antigen 85B (Ag85B). Treatment of the BMDCs with the autophagy inhibitor 3MA reduced the responses to both antigens and eliminated the increase associated with deletion of PE_PGRS47. Conversely, addition of rapamycin to activate autophagy gave increased T-cell responses, while also eliminating the enhanced responses to the ΔPE_PGRS47 strain compared to wild-type or complemented strains (Fig. 5a) . Overall, these results were consistent with an autophagy-dependent enhancement of MHC class II presentation with deletion of PE_PGRS47. To rule out the possibility that PE_PGRS47 deletion could alter the total surface level of MHC class II on infected BMDCs, we analysed this by flow cytometry. This showed no significant effect of PE_PGRS47 deletion on the total surface level of MHC class II expression in infected BMDCs compared to wild-type Mtb or complemented strains (Fig. 5b) .
To assess MHC class II presentation in vivo, we infected C57BL/6 mice with wild-type, ΔPE_PGRS47 or complemented Mtb strains and measured CD4 + T-cell responses against well-defined Mtb antigens. Lungs, spleen and mediastinal lymph nodes (MLN) were collected on different days post-infection and processed to obtain single-cell suspensions. Using flow cytometry to quantitate cells binding an MHC class II (I-A b ) tetramer containing a peptide from the secreted antigen TB9.8 (EsxG), we detected significantly more TB9.8-specific CD4 + T cells in all the organs of mice infected with the ΔPE_PGRS47 mutant compared to mice infected with wild-type or complemented strains on day 24 post-infection (Fig. 6a) . However, we were not able to detect effects on the frequency of TB9.8-specific CD4 + T cells at very early phases of infection on days 9 or 14 ( Supplementary Fig. 9 ), suggesting that PE_PGRS47 is not active in the initial stages of infection and may not affect the initial priming of T cells.
We also performed interferon-γ (IFNγ) enzyme-linked immunospot (ELISPOT) on cells isolated from infected mice to quantitate responses to immunodominant I-A b presented epitopes from Mtb antigens ESAT-6, TB9.8 and Antigen 85B (Ag85B P25) (Fig. 6b) . This showed significant increases in IFNγ-secreting CD4 + T cells specific for TB9.8 in all tissues studied on day 24 in ΔPE_PGRS47-mutant-infected mice, compared to mice infected with wild-type Mtb or the complemented strains. At this time point, we also detected a significant increase in the lungs of CD4 + T cells specific for Ag85B P25, which is known to be highly expressed by Mtb as an immunodominant antigen during early infection 26 . Surprisingly, we were not able to detect any increase in the frequency of CD4 + T cells specific for ESAT-6, possibly reflecting the rapid expression of this antigen in the early phase of infection when PE_PGRS47 may not be active, or alternatively due to the ability of ESAT-6 to directly lyse phagosomal membranes and gain access to other cellular compartments [27] [28] [29] . These effects on TB9.8 and Ag85 P25 responses persisted or became more prominent by day 60 post-infection. Together, these results indicate a significant role for PE_PGRS47 in the inhibition of MHC class II mediated antigen presentation of a subset of immunodominant CD4 + T-cell antigens beginning in early infection and persisting into the later chronic phase.
Discussion
We have provided evidence for at least five distinct genomic loci and the identity of one specific gene of Mtb that contribute to the inhibition of MHC class II restricted antigen presentation. Expression of several of these loci in Msmeg significantly prolonged intracellular survival of the bacteria, and three of them also suppressed autophagy in infected cells. Overall, these findings are consistent with the prevalent view of a highly complex programme of immune evasion that allows survival of Mtb despite an intact immune system 5 . Sequence analysis of the five cosmids isolated in our screening did not identify known virulence-related genes, but the presence of Rv2741, encoding a member of the expanded PE_PGRS protein family of Mtb, provided a strong candidate for a relevant immune evasion gene in one of the five cosmids (M2D10). Although the precise functions of PE_PGRS proteins or potential non-protein coding functions of PE_PGRS genes remain mostly unknown, previous studies have implicated members of this family in virulence and immune evasion by pathogenic mycobacteria 22, 23 . Our studies focusing on PE_PGRS47 showed that this gene significantly modulates intracellular infection. The ΔPE_PGRS47 deletion mutant of Mtb showed a reduced capacity to inhibit autophagy and an increased acidification and lysosomal fusion of phagosomes during infection of phagocytic cells (Figs 2 and 3) . In addition, infection of mice with the mutant revealed attenuated growth (Fig. 4) and a significant increase in CD4 + T-cell responses against MHC class II presented antigens (Figs 5 and 6 ). These findings indicated a non-redundant role for PE_PGRS47 in modulating innate intracellular host responses, as well as in the generation of adaptive immune responses that are critical for control of Mtb. We have not yet carried out experiments using mouse strains with specific mutations in autophagy-related genes to further confirm and explore the effects of PE_PGRS47. However, our current data using pharmacologic agents to manipulate this pathway (Figs 4d and 5a) support the hypothesis that PE_PGRS47 mediates linked inhibition of autophagy and antigen presentation in Mtb-infected cells. It is noteworthy that the expression of many PE_PGRS family members, including PE_PGRS47, is upregulated by mycobacteria after entering macrophages 30 , and that PE_PGRS47 has been reported as one of the members of this family showing the highest level of evolutionary conservation 31 . Autophagy has received considerable attention as a basic cellular mechanism contributing to both innate and adaptive immunity 32 , and as a mechanism that enhances clearance of intracellular mycobacteria 33 . It has been frequently emphasized that Mtb inhibits phagosome maturation, preventing acidification of phagosomes harbouring live bacilli and their fusion with lysosomes 34 . Recent work suggests that this critical feature of Mtb survival and immune evasion is at least in part due to the suppression of autophagy 14, 35, 36 . Although a recent report has called into question the relevance of autophagy as a mechanism of host protection in the mouse model 37 , this may reflect the ability of Mtb to efficiently disable and manipulate this pathway. Several of our findings were consistent with the expected effect of enhanced autophagy on promoting killing of Mtb by innate immunity (Fig. 4c and Supplementary Fig. 8a ), but it was surprising that growth of the ΔPE_PGRS47 mutant was not significantly attenuated in the early phase of infection in wild-type mice ( Fig. 4a and Supplementary  Fig. 7f ). This suggests that other mediators may be produced by Mtb that play a more dominant role during the early phases of infection in vivo to prevent autophagy or to neutralize its microbicidal effects.
Overall, our results identify the product of the PE_PGRS47 gene as one potentially important factor contributing to the modulation of the host cell environment by Mtb. The mechanism by which PE_PGRS47 mediates this function remains to be determined, although our results indicate that this protein is secreted by the bacteria and gains access to the cytosol of infected host cells (Supplementary Fig. 6 ). Access to the host cell cytoplasm has been described for other PE_PGRS proteins, such as PE_PGRS33, which has been reported to localize to mitochondria to modulate cell death 38 . Specific interacting partners for PE_PGRS proteins within the host-cell proteome have not yet been identified, and this represents an important future area of discovery that may yield clues to the mechanisms of action of PE_PGRS47 and other members of this family.
Methods
Antibodies and other reagents. Monoclonal antibody Y-Ae was purified from hybridoma culture supernatants by standard protein G column chromatography (Amersham Biosciences/GE Healthcare). Purified mAbs (2.0 mg ml -1 in PBS) were biotinylated overnight at 4°C using NHS-LC-biotin (N-Hexanoate-succinimidyllong chain-biotin, Thermo scientific), dissolved to 10 mM with DMSO just before use, with a biotin-to-mAb molar ratio of 30:1. Unbound biotin was not removed, as this did not interfere with downstream applications. Anti-I-A/I-E-FITC (fluorescein isothiocyanate ) and anti-CD11c-PE mAbs were obtained from BD Biosciences. Rapamycin was from Calbiochem and IFNγ was from Peprotech. 3-Methyladenine was from Sigma. The nuclear fluorescent dye 4,6-diamidino-2-phenylindole (DAPI) was purchased from Sigma. Anti-LC3 antibodies for western blotting and immunofluorescence analysis were purchased from Novus Biologicals and Cell Signaling, respectively. Antibodies to LAMP-1, β-actin and p62 were purchased from Abcam.
Bacterial strains and culture conditions. Wild-type Mtb (strain H37Rv), mutant and complemented strains or Msmeg (strain mc 2 155) were cultured at 37°C in Middlebrook 7H9 broth, or on 7H10 or 7H11 agar containing 10% (vol/vol) oleic acid-albumin-dextrose-catalase (OADC), 0.5% glycerol and 0.05% (vol/vol) tyloxapol. Escherichia coli strain DH5α was used for cloning purposes and grown on Luria-Bertani agar or broth at 37°C. Strains bearing antibiotic resistance cassettes were cultured in the presence of hygromycin (50 µg ml -1 for mycobacterial selection or 150 µg ml -1 for E. coli) or kanamycin (20 µg ml -1 for mycobacterial selection or 40 µg ml -1 for E. coli). Strains of Msmeg and Mtb were transformed using published protocols 39 . The PE_PGRS47 gene was deleted from Mtb H37Rv by allelic exchange via the previously described specialized phage transduction method 24 . Colonies were selected for hygromycin resistance following transduction, screened for gene deletion by PCR and confirmed by Southern blotting using previously described methods 24 . For complementation of the ΔPE_PGRS47 mutant, a full-length Mtb PE_PGRS47 (Rv2741) gene was amplified by PCR from Mtb H37Rv genomic DNA and cloned into pMV361, an integrating Mtb vector with an hsp60 promoter 40 .
Construction of Mtb genomic DNA library. The strategy for generation of the Mtb genomic library in cosmid vector pYUB412 has been described previously 47 . Briefly, M. tuberculosis (strain H37Rv) genomic DNA was purified and partially digested with Sau3A. Agarose gel purification was used to enrich for DNA fragments of ∼40 kb, which were ligated into the arms of cosmid vector pYUB412 digested with BamH1. DNA was packaged into phages in vitro with Gigapack XL (Stratagene) and E. coli were transduced and selected on LB plates containing 100 µg ml -1 ampicillin. Over 1 × 10 5 independent clones were pooled, and DNA for transformation was obtained using standard alkaline lysis method.
Construction and expression of ESAT6-IEα fusion protein.
A sequence of 87 bp containing the coding sequence for the MHC class II-presented IEα epitope (EFAKFASFEAQGALANIAVDKANLD) 48 was synthesized (GenScript) and then ligated into pMV261 containing the ESAT6 sequence to create a fusion of the IEα sequence to the C-terminal sequence of ESAT6. The resulting plasmid, pMV261-ESAT6-IEα, was introduced into M. smegmatis by electroporation.
Construction and screening of M. smegmatis clones expressing Mtb cosmids. The Mtb cosmid DNA library was electroporated into M. smegmatis harbouring the pMV261-ESAT6-IEα plasmid. A total of 365 random clones from the cosmid transformation of M. smegmatis were picked and grown in liquid medium (7H9) containing hygromycin (50 µg ml -1 ). Assuming a random distribution of Mtb sequences among the cosmid transformants and an average insert size of ∼40 kb, the 365 cosmid clones represented approximately three times coverage (×C ) of the entire Mtb genome (that is, ×C = L[N/G], where L is the average length of the genomic fragments represented by the inserts, N is the number of inserts, and G is the entire genome length). At this level of coverage, the probability of any given genomic 40 kb fragment being represented in a group of N cosmids is given by the formula P = 1 -e −R , where R = NL/G (ref. 49 ). For a library of 365 random cosmid clones, P ≅ 0.95, indicating an approximately 95% chance that any given gene in Mtb will be assessed at least once in the initial screening. Cultures of BMDCs were infected at a multiplicity of infection (MOI) of 20:1 for 3 h individually with each of the 365 M. smegmatis clones containing Mtb cosmids. As a positive control, BMDCs were similarly infected with M. smegmatis expressing ESAT6-IEα and transformed with the empty pYUB412 cosmid vector. After 3 h, cells were treated with gentamicin (100 µg ml ; Invitrogen) for 1 h to inhibit the growth of extracellular bacteria and the cells were then washed two times with PBS and cultured in fresh medium containing 20 µg ml -1 of gentamicin. Cells were detached with cold PBS containing 1 mM EDTA at 24 h post-infection and were stained with the Y-Ae monoclonal antibody (specific for complexes of I-A b /Eα peptide) and with mAbs specific for CD11c and for total MHC class II (I-A/I-E specific). Cell surface staining was measured by flow cytometry using a FACSCalibur (BD Biosciences). A total of 72 transformant clones of M. smegmatis showing significantly reduced Y-Ae staining (>3 standard errors below the mean value of 12 replicates of control clones containing an empty cosmid vector) were identified in primary screening. These were assessed for maintenance of expression of the ESAT6-IEα fusion protein by western blotting using anti-ESAT6 and anti-Hsp65 mAbs to assess the relative levels of the fusion protein with endogenous Hsp65 in each clone (see Supplementary  Fig. 2a for an example) . Eighteen of the 72 transformant clones initially selected by the primary screen (that is, 25%) showed reduced expression of the ESAT6-IEα fusion protein (ratio of Hsp65:ESAT6-IEα > 3 standard errors above values for empty cosmid control transformants) and these were excluded from subsequent secondary screening to eliminate false positives.
Cosmid recovery from M. smegmatis. Although pYUB412 is an integrating vector that inserts at a specific chromosomal site in M. smegmatis 50 , we observed in preliminary studies that a small but significant amount of our integrated cosmids could be recovered by simple extraction from lysozyme-treated bacteria. This is due to a low rate of spontaneous excision and reinsertion of cosmids built in the pYUB412 backbone, which results in a constant low level of cells containing unintegrated circular cosmids. To recover these cosmids, M. smegmatis clones were grown in 250 ml of 7H9 medium at 37°C overnight, collected by centrifugation, and resuspended in 4 ml of Glu TE buffer (50 mM glucose, 10 mM EDTA, 25 mM Tris, pH 7.5) with 10 mg ml -1 of lysozyme. The samples were incubated at 37°C overnight. Then 40 ml of lysis buffer (1%SDS and 0.2 M NaOH) was added, mixed by inversion and incubated for 10 min on ice. After this, 40 ml of neutralization buffer (3 M potassium acetate, 2 M acetic acid) was added, mixed, and incubated for 10 min on ice. The samples were centrifuged and cleared by filtration through tissue paper to remove insoluble debris. Then 40 ml of 2-propanol was added to the supernatant, mixed and incubated for 10 min on ice, followed by centrifugation at 1,400g for 20 min. The pellets were recovered and resuspended in 4 ml of ultrapure water. A 4 ml volume of RNA precipitation buffer (5 M LiCl, 50 mM Tris, pH 7.6) was then added and incubated for 10 min on ice. The samples were centrifuged for 10 min at 1,400g, and the supernatant was transferred to a new tube in which the DNA was precipitated by adding 80 µl of 10 M sodium acetate and 650 µl of ethanol, incubated at −20°C for 20 min and then centrifuged. The pellets were washed twice with 70% ethanol, dried at room temperature and then resuspended in 100 µl of TE buffer.
DNA sequencing. The Mtb genomic DNA insert of each cosmid was first sequenced using primers specific for the sequences of the pYUB412 vector flanking the insert (pYB412F-5′-gtacgccaccgcctggttc-3′ and pYUB412R-5′-gtgccacctgacgtctaag-3′) which provided ∼400 bp of Mtb genomic sequence corresponding to the 5′ and 3′ ends of the insert. Because initial analysis of the ends of the inserts revealed that they were composed of more than one fragment of genomic DNA that had been ligated in tandem, it was necessary to use a cosmid walking approach to obtain the complete sequences of the cosmid inserts. Sequencing by cosmid walking was done by starting from the distal portion of the known sequences at the ends of each insert. Deoxyoligonucleotides were designed based on the Mtb H37Rv genome sequence (http://genolist.pasteur.fr/TubercuList/) to be complementary to sequences located at 1 kbp intervals upstream of the known sequence and standard sequencing reactions were carried out using these as primers. Sequence information obtained from these reactions was used to design a second set of primers, and the process was repeated until all of the regions of the insert that were non-contiguous with the Mtb genomic sequence had been sequenced directly. This information was then used together with the published genomic sequence to assemble the complete insert sequence.
Animal experiments. Wild-type C57BL/6 or severe combined immunodeficiency (SCID; also in C57BL/6 background) female mice between six and eight weeks of age were purchased from Jackson Laboratories. Formal power calculations were not done for animal group size selection, although the minimum group size (N = 5) is typical for experiments to assess major effects on mycobacterial growth and virulence in the mouse infection model. This group size allows valid statistical testing in experiments with multiple groups. Animals were assigned randomly to experimental groups and studies using mice were not blinded. T cell receptor transgenic TEα mice (rag1−/− and expressing CD90.1) were a gift from Marc K. Jenkins (University of Minnesota). C57BL/6 mice were infected with Mtb or ΔPE_PGRS47 or complemented strains through aerosol exposure as previously described 41 . SCID mice were infected i.v. via the tail vein with 1 × 10 6 c.f.u. per mouse. Lung tissues were processed for histopathology using standard paraffin fixation, sectioning and H&E staining. All mice were maintained under specific pathogen-free conditions. All procedures involving the use of animals were in compliance with protocols approved by the Albert Einstein College of Medicine Institutional Animal Use and Biosafety Committees.
Primary cell culture and cell lines. BMDCs were prepared as described 42 . Briefly, bone marrow was obtained from tibiae and femurs of six-to eight-week-old female C57BL/6 mice. Cells were seeded at 2 × 10 6 per 100 mm in bacteriological Petri dishes (VWR) in 10 ml of complete RPMI-1640 medium (Invitrogen) supplemented with 10 mM HEPES, 2 mM L-glutamine, 55 µM 2-mercaptoethanol, 50 μg ml -1 penicillin/streptomycin and 10% ultralow IgG heat-inactivated (56°C, 30 min) fetal bovine serum (FBS; Atlanta Biologicals) and murine granulocyte-macrophage colony-stimulating factor (GM-CSF) (20 ng ml -1 ) (Peprotech). Cell cultures were fed with 10 ml of medium on days 3, 6 and 8 and collected on day 10. Bone marrow macrophages (BMMs) were derived according to previously published methods 43 . Briefly, marrow flushed from the tibia and femurs of six-to eight-week-old C57BL/6 mice was collected aseptically and cultured in non-tissue-culture-treated 100 × 20 mm serological plates (Fisher) at a density of 2 × 10 5 cells per ml in BMM medium (DMEM supplemented with 1% HEPES, 1% L-glutamine, 1% non-essential amino acids, 100 U ml -1 penicillin and 100 µg ml -1 streptomycin (all from Invitrogen), 10% FBS (HyClone/GE Healthcare) and 10% L929 fibroblast-conditioned medium) for 6 days. On day 6, adherent cells were collected after detachment by incubation for 20 min at 4°C with 5 mM EDTA in PBS.
THP-1 cells (American Type Culture Collection (ATCC)) were grown in RPMI-1640 (Invitrogen) supplemented with 10% FBS, 1% HEPES, 1% non-essential amino acids and essential amino acids and 50 µg ml -1 of penicillin and streptomycin (complete RPMI). THP-1 cells were treated with 40 ng ml -1 phorbol ester (PMA; Sigma-Aldrich) overnight to induce their differentiation into macrophage-like cells. The J774 macrophage cell line (ATCC) was transduced to express a GFP-LC3 fusion protein using a lentivirus construct provided by N. Mizushima (Department of Physiology and Cell Biology, Tokyo Medical and Dental University) 44 . The J774-GFP-LC3, RAW 264.7 (ATCC) and AMJ2-C8 (ATCC) mouse macrophage lines were grown in DMEM supplemented with 1% HEPES, 1% l-glutamine, 1% non-essential amino acids, 100 U ml -1 penicillin, 100 µg ml -1 streptomycin (all from Invitrogen) and 10% FBS (HyClone). Immediately before infection with mycobacteria, these cells were washed and incubated with antibiotic-free media containing non-decomplemented FBS. Infections of cultured cells with mycobacteria were generally done for 3 h at 37°C in a 5% CO 2 incubator, followed by washing three times with PBS and then culturing in fresh medium containing 100 µg ml -1 of gentamicin for 1 h. This was followed by washing and then incubation in media with gentamicin at 20 µg ml -1 for the additional indicated time periods. Approximately half of the culture medium was removed and replaced with fresh medium on day 3 of culture to improve viability through day 5.
The cell lines used in this study were authenticated and tested for mycoplasma at their source (ATCC) and were not tested subsequently for mycoplasma contamination.
Analysis of T-cell responses. To derive CD4 + T-cell lines specific for the I-A b presented Eα peptide, splenocytes from TEα transgenic mice were isolated by negative depletion (Pan T cell isolation kit, Miltenyi Biotech) and cultured with IEα peptide (10 µg ml -1 ) in the presence of Gardiquimod (1 μg ml
) and poly I:C (10 μg ml -1 ) for 7 days. The cells were then rested for an additional 7 days in the presence of irradiated syngeneic splenocytes, IL-2 (20 ng ml ) and IL-7 (10 ng ml -1 ), after which they were again stimulated using IEα peptide plus irradiated splenocytes. After three cycles of restimulation followed by resting, the cells were collected and used for T-cell activation experiments.
Capture enzyme-linked immunosorbent assays (ELISA) for the detection of cytokines in supernatants of T-cell cultures were carried out as described previously 45 . Briefly, culture supernatants were collected after 72 h at 37°C, and levels of IL-2 and IFNγ were quantified using specific capture and biotinylated detection mAb pairs (BD Biosciences), streptavidin-HRP (BD Biosciences) and TMB substrate (Sigma-Aldrich) as substrate. Recombinant cytokines (PeproTech) were used to generate standard curves. Measurements were performed in triplicate. Quantitation of IFNγ secreting CD4 + T cells by ELISPOT was done as described previously 41 , using synthetic peptides (10 µg ml -1 ) corresponding to Mtb epitopes Ag85B 240-254 (Peptide 25), ESAT6 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] and TB9.8 [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] for in vitro restimulation.
Fluorescence-activated cell sorting (FACS) analysis. Cells were suspended in FACS buffer (PBS, 2% FCS and 0.05% NaN 3 ) and Fc receptors were blocked by incubation for 5 min with a 1/10 dilution of a culture supernatant of the rat 2.4G2 hybridoma (specific for murine FcγRIII (CD16) and FcγRIIb (CD32)). Cells were stained with specific fluorochrome-labelled antibodies or peptide-loaded MHC class II tetramers in FACS buffer for 1 h at room temperature, washed twice and then resuspended in FACS buffer. Cells were analysed using a four-colour FACSCalibur cytometer (BD Biosciences).
Fluorescence microscopy and autophagy analysis. Autophagy was evaluated in infected cells by immunostaining of LC3 or by western blotting analysis as described previously 46 . For the quantification of autophagy, the percentages of GFP-LC3-positive autophagic vacuoles in J774 GFP-LC3 transfected cells, or the numbers of endogenous LC3 puncta in primary cells were evaluated using fluorescence microscopy. For immunostaining, macrophages with or without previous mycobacteria infection were seeded in wells of 24-well plates that contained roundglass coverslips at a density of 1×10 5 cells per well in 1 ml of medium. For endogenous LC3 staining, cells were fixed with methanol at −20°C for 20 min. For LAMP-1 staining, cells were fixed with 4% paraformaldehyde in PBS at 4°C for 10 min and permeabilized with 0.01% Triton X-100 in PBS for 12 min before being treated with 10% bovine serum albumin (BSA) for 1 h at 25°C. The cultures were then stained with primary antibodies, including rabbit anti-mouse LC3 (1:200; Cell Signaling) or rat anti-mouse LAMP-1 (1:200; Abcam) overnight at 4°C. After washing to remove excess primary antibodies, the cultures were incubated for 2 h at room temperature with anti-rabbit IgG-Alexa 488 or anti-rat IgG-Alexa 647. In some experiments, RAW264.7 cells were loaded with Lysotracker DND RED (Life Technologies) and infected with different Mtb strains (wild type, ΔPE_PGRS47 or complemented strain), which were fluorescently labelled with FITC (Sigma) for the indicated time periods and then washed three times with PBS before fixation for immunostaining. After washing, the sections were mounted with ProLong Gold (Invitrogen). Confocal images were acquired with a Leica SP5 AOBS (Leica Microsystems). Co-localization of fluorescent bacilli with lysosomal or autophagosomal markers was quantitated by direct visual scoring by a blinded observer, and by computer-assisted image analysis using ImageJ software (http://rsbweb.nih.gov/ij/). Criteria for the visual scoring were that positive scoring for co-localization had to satisfy two criteria: (1) the fluorescence from the marker being assessed had to surround more than half of the bacterial surface; and (2) the marker staining had to be of sufficient intensity for the co-localized bacteria to appear distinctly yellow. In terms of quantitation, similar results were obtained using direct visual scoring and ImageJ analysis. The values of means ± s.e. of co-localization shown in Figs 2 and 3 were obtained with the direct visual scoring method. Endogenous LC3 conjugation was evaluated by western blot analysis using an antibody specific for LC3-I/II. As a positive control for autophagy activation, cells were treated with complete media contained 1 µM rapamycin (Sigma) for 12 h.
Electron microscopy. Transmission-electron microscopy was used to analyse the morphology of phagosomal membranes and to confirm the induction of autophagy.
After infection with mycobacteria, cells were fixed with 2% glutaraldehyde in 0.1 M cacodylate at room temperature for 2 h and then incubated overnight in 4% formaldehyde, 1% glutaraldehyde and 0.1% PBS. After fixation, the samples were stained for 90 min in 2% osmium, then serially dehydrated in ethanol and embedded in Spurr's epoxy resin. Thin sections were obtained on an Ultracut cryotome and stained with 0.5% uranyl acetate and 0.5% lead citrate (Reichart). Samples were examined in a JEOL 1200EX transmission electron microscope operating at 80 kV. Immunogold electron microscopy was performed to analyse the presence of PE_PGRS protein after infection of macrophages with Msmeg or Msmeg-PE_PGRS47 using previously described methods 51 . Briefly, the macrophages were fixed in 0.1 M sodium cacodylate buffer (pH 7.2) containing 4% paraformaldehyde, 0.2% glutaraldehyde, infiltrated in 25% polyvinylpyrrolidone and 2.1 M sucrose and then rapidly frozen by immersion in liquid nitrogen. Cryosections were obtained in the temperature range from −70 to −90°C using an Ultracut cryotome. After blocking with PBS-BSA with 50 mM NH 4 Cl, the cryosections were incubated overnight in the presence of the mouse monoclonal antibody mAb 7C4.1F7. After incubation with Immunogold-labelled anti-mouse IgG, specimens were observed in a JEOL1200EX transmission electron microscope operating at 80 kV.
